A recent study showed that pro-inflammatory macrophages (M1) exhibit effector potential through activation of NLRP3 inflammasome (60) leading to the production of IL-1β and IL-18, an important pathway in the pathogenesis of rheumatic diseases (61, 62). Here, IL1B is linked to rheumatic disorder.